Mirum Pharmaceuticals, Inc.
MIRMFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Mirum Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Pathstone Holdings, LLC | 2026-03-31 | 25,575 | $2.36M | SEC filing |
| GF FUND MANAGEMENT CO. LTD. | 2026-03-31 | 1,155 | $107K | SEC filing |
| Legato Capital Management LLC | 2026-03-31 | 41,763 | $3.86M | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 1,260,003 | $116M | SEC filing |
| D. E. Shaw & Co., Inc. | 2026-03-31 | 167,489 | $15.5M | SEC filing |
| FARMERS & MERCHANTS INVESTMENTS INC | 2026-03-31 | 2 | $185 | SEC filing |
| RiverPark Advisors, LLC | 2026-03-31 | 2,014 | $186K | SEC filing |
| Westside Investment Management, Inc. | 2026-03-31 | 300 | $27.7K | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 42 | $3.88K | SEC filing |
| VICTORY CAPITAL MANAGEMENT INC | 2026-03-31 | 95,555 | $8.83M | SEC filing |
| Ensign Peak Advisors, Inc | 2026-03-31 | 202,473 | $18.7M | SEC filing |
| Larson Financial Group LLC | 2026-03-31 | 141 | $13K | SEC filing |
| Thrivent Financial for Lutherans | 2026-03-31 | 57,061 | Not shown | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 19,532 | $1.8M | SEC filing |
| SummitTX Capital, L.P. | 2026-03-31 | 4,170 | $385K | SEC filing |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2026-03-31 | 16,376 | $1.51M | SEC filing |
| Essential Partners LLC | 2026-03-31 | 5 | $462 | SEC filing |
| Aquatic Capital Management LLC | 2026-03-31 | 16,983 | $1.57M | SEC filing |
| ALPS ADVISORS INC | 2026-03-31 | 49,128 | $4.54M | SEC filing |
| HighVista Strategies LLC | 2026-03-31 | 15,563 | $1.44M | SEC filing |
- Each value is checked against Mirum Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Mirum Pharmaceuticals, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Mirum Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-16 · Peetz Christopher: Larger than 62 of the 66 other insider sales of Common Stock on file. SEC filing
- 2026-01-23 · Heron Patrick J: Larger than all 10 other insider purchases of Common Stock on file. SEC filing
- 2025-12-19 · GREY MICHAEL G: Larger than 63 of the 66 other insider sales of Common Stock on file. SEC filing
- 2025-12-01 · GREY MICHAEL G: Larger than 63 of the 66 other insider sales of Common Stock on file. SEC filing
- 2025-11-21 · GREY MICHAEL G: Larger than 63 of the 66 other insider sales of Common Stock on file. SEC filing
- 2025-08-11 · Peetz Christopher: Larger than 60 of the 66 other insider sales of Common Stock on file. SEC filing
- 2025-08-07 · Peetz Christopher: Larger than 60 of the 66 other insider sales of Common Stock on file. SEC filing
- 2025-03-17 · Howe Jolanda: Larger than all 66 other insider sales of Common Stock on file. SEC filing
- 2025-03-06 · Heron Patrick J: Larger than 9 of the 10 other insider purchases of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-17 | Howe Jolanda · SVP, GLOBAL CONTROLLER | Common Stock | S — Open market or private sale | −2,594 | 101.95 | SEC filing |
| 2026-06-08 | BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −1,567 | 95.12 | SEC filing |
| 2026-06-08 | BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −2,258 | 92.84 | SEC filing |
| 2026-06-08 | BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −1,175 | 93.95 | SEC filing |
| 2026-06-01 | Peetz Christopher · CHIEF EXECUTIVE OFFICER | Common Stock | S — Open market or private sale | −883 | 99.66 | SEC filing |
| 2026-06-01 | Peetz Christopher · CHIEF EXECUTIVE OFFICER | Common Stock | S — Open market or private sale | −1,973 | 97.56 | SEC filing |
| 2026-06-01 | Peetz Christopher · CHIEF EXECUTIVE OFFICER | Common Stock | S — Open market or private sale | −6,926 | 96.15 | SEC filing |
| 2026-06-01 | Peetz Christopher · CHIEF EXECUTIVE OFFICER | Common Stock | S — Open market or private sale | −1,021 | 98.20 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-15 | Cardon Lon · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,772 | SEC filing |
| 2026-06-15 | Cardon Lon · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +1,980 | SEC filing |
| 2026-06-15 | Heron Patrick J · Director | Deferred Stock Units | A — Grant, award, or other acquisition | +1,980 | SEC filing |
| 2026-06-15 | Brege Laura · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,772 | SEC filing |
| 2026-06-15 | Fischer Laurent · Director | Deferred Stock Units | A — Grant, award, or other acquisition | +1,980 | SEC filing |
| 2026-06-15 | Ramasastry Saira · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,772 | SEC filing |
| 2026-06-15 | Walbert Timothy P · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,772 | SEC filing |
| 2026-06-15 | Heron Patrick J · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,772 | SEC filing |
Showing 8 of 21 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-01-23 | Heron Patrick J · Director | Common Stock | J — Other acquisition or disposition | +159,277 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.